NEWS FROM LTS

Company news

LTS and Revive Therapeutics enter into Feasibility Agreement to develop Oral Psilocybin Thin Film Strip

2021-05-17T17:20:13+02:0017.05.2021|Company News|

LTS and Revive Therapeutics Ltd. are pleased to announce that they have entered into a feasibility agreement to develop and manufacture a proprietary oral psilocybin thin film strip for the Company’s clinical and commercial initiatives to evaluate in mental illness, neurological and substance abuse disorders.

Go to Top